Skip to content

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of the Neck Nodes With Unknown Primary Malignancy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00530283
Enrollment
20
Registered
2007-09-17
Start date
2007-08-31
Completion date
2010-07-31
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Cell Cancer

Keywords

Squamous, Unknown Primary, Patients with Squamous cell cancer neck nodes

Brief summary

Patients with squamous cell cancer of neck nodes but unknown primary will have a PET-CT scan prior to biopsies. The utility of PET-CT will be determined in this subset of patients.

Interventions

OTHERPET-CT

Sponsors

Calgary Health Region
CollaboratorOTHER
University of Calgary
CollaboratorOTHER
AHS Cancer Control Alberta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* squamous cell cancer of neck nodes with unknown primary site

Exclusion criteria

* unable to tolerate PET-CT * unable to undergo examination under anaesthesia

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026